Changes to medication abortion clinical practices in response to the COVID-19 pandemic

The concentration of fetal red blood cells in first-trimester pregnant women undergoing uterine aspiration is below the calculated threshold for Rh sensitization

(2020) Sarah Horvath et al.   CONTRACEPTION

Commentary: No-test medication abortion: A sample protocol for increasing access during a pandemic and beyond

(2020) Elizabeth G. Raymond et al.   CONTRACEPTION

Foregoing Rh testing and anti-D immunoglobulin for women presenting for early abortion: a recommendation from the National Abortion Federation's Clinical Policies Committee

(2019) Alice Mark et al.   CONTRACEPTION

Telemedicine for medical abortion: a systematic review

(2019) Margit Endler et al.   BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY

TelAbortion: evaluation of a direct to patient telemedicine abortion service in the United States

(2019) Elizabeth Raymond et al.   CONTRACEPTION

Low-sensitivity urine pregnancy testing to assess medical abortion outcome: A systematic review

(2018) Elizabeth G. Raymond et al.   CONTRACEPTION

Abortion through telemedicine

(2018) Wing Kay Fok et al.   CURRENT OPINION IN OBSTETRICS & GYNECOLOGY

Sixteen Years of Overregulation: Time to Unburden Mifeprex

(2017)   NEW ENGLAND JOURNAL OF MEDICINE

Reaching women where they are: eliminating the initial in-person medical abortion visit

(2015) Elizabeth G. Raymond et al.   CONTRACEPTION

Alternatives to ultrasound for follow-up after medication abortion: a systematic review

(2010) Daniel Grossman et al.   CONTRACEPTION

Medication Abortion

(2009) DEBORAH BARTZ et al.   CLINICAL OBSTETRICS AND GYNECOLOGY

Feasibility of telephone follow-up after medical abortion

(2009) Lisa K. Perriera et al.   CONTRACEPTION